Sometimes referred to as the "crown jewel" of the UK's technology sector, Arm was founded in Cambridge, England, in 1990. Arm Limited (“Arm”) has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of American depositary shares representing Arm’s ordinary shares. The Arm IPO will likely double, or possibly triple, the $3.5 billion listing of Kenvue, the consumer health business of Johnson & Johnson